EDWARD MASON to Moxalactam
This is a "connection" page, showing publications EDWARD MASON has written about Moxalactam.
Connection Strength
0.074
-
Follow-up of prospective randomized trial of ampicillin or chloramphenicol versus moxalactam treatment of Haemophilus influenzae type b meningitis. J Pediatr. 1988 May; 112(5):795-8.
Score: 0.019
-
Prospective comparative trial of moxalactam versus ampicillin or chloramphenicol for treatment of Haemophilus influenzae type b meningitis in children. J Pediatr. 1984 Mar; 104(3):447-53.
Score: 0.014
-
Pharmacokinetics of moxalactam in anuric children and during hemodialysis. Pediatr Pharmacol (New York). 1983; 3(1):29-36.
Score: 0.013
-
In vitro susceptibility of 104 clinical isolates of Haemophilus influenzae to moxalactam (LY127935), ampicillin, chloramphenicol, and ticarcillin. Antimicrob Agents Chemother. 1980 Mar; 17(3):470-3.
Score: 0.011
-
Moxalactam treatment of serious infections primarily due to Haemophilus influenzae type b in children. Pediatrics. 1983 Feb; 71(2):187-91.
Score: 0.003
-
Pharmacology and cerebrospinal fluid penetration of moxalactam in children and dosage recommendations. Rev Infect Dis. 1982 Nov-Dec; 4 Suppl:S597-602.
Score: 0.003
-
Successful moxalactam therapy for gram-negative bacillary meningitis in neonates. South Med J. 1982 May; 75(5):632-3.
Score: 0.003
-
Use of moxalactam for bacterial meningitis. J Pediatr. 1982 May; 100(5):843.
Score: 0.003
-
Relapse of Escherichia coli meningitis following therapy with moxalactam. Pediatr Infect Dis. 1982 Jan-Feb; 1(1):24-8.
Score: 0.003
-
Pharmacokinetics and cerebrospinal fluid penetration of moxalactam in children with bacterial meningitis. J Pediatr. 1981 Jan; 98(1):152-7.
Score: 0.003